MCM Capital

Home Education Blog RMB Products Enters Life Sciences Market

RMB Products Enters Life Sciences Market

In April 2018, RMB announced the launch of CryoVault™ (https://www.meissner.com/products/cryovault-freeze-thawplatform). The product, a proprietary, scalable, robust,  single-use freeze and thaw platform for the storage of high value biopharmaceuticals, was developed in partnership with Merck.  RMB has partnered with Meissner Filtration Products, a leading biopharma equipment supplier, as its exclusive distributor to market the system. The Cryovault system has significant advantages over competing flexible packaging solutions.  The platform is scalable up to volume requirements of 75 L.  Further, CryoVault™ uses robust rigid wall single-use assemblies to protect your product from fill to dispense ensuring fluid integrity which can be a challenge with flexible packaging.

This represents RMB’s first major entry into the life sciences space, a market MCM believes RMB can grow into through leveraging its unique high purity plastics rotational molding capabilities.

Capital ideas,
delivered to your inbox

Posts by Topic

Recent Posts
View All
MCM Capital Partners Acquires AIM Processing

MCM Capital Partners (“MCM”), a micro-cap private equity firm based in Cleveland, Ohio, is pleased to announce its recent acquisition of AIM Processing based in Longmont, CO. AIM Processing is a custom plastic injection molder specializing in small, tight-tolerance parts and are experts in overmolding, insert molding, and metal replacement serving the medical device, industrial,...

Read Blog
MCM Capital Acquires Tech NH

Cleveland, OH –MCM Capital Partners (“MCM”), a micro-cap private equity firm based in Cleveland, Ohio, is excited to announce the majority recapitalization of Tech NH, Inc. (“Tech” or the “Company”). Tech, based in Merrimack, New Hampshire, is a technical injection molder serving the medical device, general industrial, defense and green energy industries. Founded in 1982...

Read Blog
How Do Private Equity Funds Decide When To Sell Portfolio Companies?

As a private equity fund focused on lower middle market manufacturing and distribution businesses, we are often asked about our eventual plans to sell portfolio companies. Private equity investors typically have a planned investment horizon (typically 5-7 years) during which they expect to hold, grow and exit a portfolio company. However, the exact timing of...

Read Blog
4 Questions To Ask A Potential Private Equity Buyer

Partnering with a private equity fund is sure to have a transformative effect on any business. Gaining clarity on these topics will help determine whether a private equity suitor can be a potential long-term growth partner. 

Read Blog